Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 3
1983 1
1984 1
1985 2
1986 6
1987 4
1989 7
1990 2
1991 8
1992 5
1993 4
1994 5
1995 7
1996 9
1997 4
1998 2
1999 6
2000 9
2001 13
2002 28
2003 36
2004 30
2005 46
2006 39
2007 42
2008 42
2009 57
2010 67
2011 70
2012 75
2013 71
2014 57
2015 86
2016 83
2017 58
2018 66
2019 67
2020 74
2021 68
2022 59
Text availability
Article attribute
Article type
Publication date

Search Results

1,202 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY; South China Breast Cancer Group (SCBCG). Wang X, et al. Among authors: zhang lh. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. JAMA. 2021. PMID: 33300950 Free PMC article. Clinical Trial.
Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
Wang Y, Li N, Yang JJ, Zhao DM, Chen B, Zhang GQ, Chen S, Cao RF, Yu H, Zhao CY, Zhao L, Ge YS, Liu Y, Zhang LH, Hu W, Zhang L, Gai ZT. Wang Y, et al. Among authors: zhang lh. Pharmacol Res. 2020 Jul;157:104784. doi: 10.1016/j.phrs.2020.104784. Epub 2020 Apr 17. Pharmacol Res. 2020. PMID: 32305492 Clinical Trial.
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).
Hua X, Bi XW, Zhao JL, Shi YX, Lin Y, Wu ZY, Zhang YQ, Zhang LH, Zhang AQ, Huang H, Liu XM, Xu F, Guo Y, Xia W, Hong RX, Jiang KK, Xue C, An X, Zhong YY, Wang SS, Huang JJ, Yuan ZY. Hua X, et al. Among authors: zhang lh. Clin Cancer Res. 2022 Feb 15;28(4):637-645. doi: 10.1158/1078-0432.CCR-21-3435. Clin Cancer Res. 2022. PMID: 34810217 Clinical Trial.
[Maternal vascular malperfusion].
Zhang DC, Zhang LH, Zhao CQ. Zhang DC, et al. Among authors: zhang lh. Zhonghua Bing Li Xue Za Zhi. 2020 Sep 8;49(9):988-992. doi: 10.3760/cma.j.cn112151-20191227-00832. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32892577 Chinese.
GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.
Bai F, Zhang LH, Liu X, Wang C, Zheng C, Sun J, Li M, Zhu WG, Pei XH. Bai F, et al. Among authors: zhang lh. Theranostics. 2021 Jul 13;11(17):8218-8233. doi: 10.7150/thno.59280. eCollection 2021. Theranostics. 2021. PMID: 34373738 Free PMC article.
Quorum sensing and microbial drug resistance.
Chen YF, Liu SY, Liang ZB, Lv MF, Zhou JN, Zhang LH. Chen YF, et al. Among authors: zhang lh. Yi Chuan. 2016 Oct 20;38(10):881-893. doi: 10.16288/j.yczz.16-141. Yi Chuan. 2016. PMID: 27806929 Review.
1,202 results